Confirmation study of PTEN mutations among individuals with autism or developmental delays/mental retardation and macrocephaly

Autism Research

Volumn 3, Issue 3, 2010, Pages 137-141

  McBride, Kim L ^a,b   Varga, Elizabeth A ^a,b   Pastore, Matthew T ^a,b   Prior, Thomas W ^b   Manickam, Kandamurugu ^a,b   Atkin, Joan F ^a,b   Herman, Gail E ^a,b  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Autism; Cancer; Cowden syndrome; Developmental delay; Genetic; Molecular genetics; PTEN

Indexed keywords

PHOSPHATASE; PTEN ENZYME; UNCLASSIFIED DRUG;

ARTICLE; AUTISM; BREAST CANCER; CASE REPORT; COWDEN SYNDROME; FEMALE; GENE MUTATION; HUMAN; INFANT; KIDNEY CANCER; MACROCEPHALY; MALE; MENTAL DEFICIENCY; MISSENSE MUTATION; PRIORITY JOURNAL; PROSTATE CANCER; AUTISTIC DISORDER; CEPHALOMETRY; CHILD; COMORBIDITY; CRANIOFACIAL ABNORMALITIES; DEVELOPMENTAL DISABILITIES; GENETICS; GENOTYPE; INTELLECTUAL DISABILITY; LEARNING DISORDERS; NEOPLASMS; NUCLEOTIDE SEQUENCE; PEDIGREE; PHENOTYPE; PRESCHOOL CHILD;

AUTISTIC DISORDER; CEPHALOMETRY; CHILD; CHILD, PRESCHOOL; COMORBIDITY; CRANIOFACIAL ABNORMALITIES; DEVELOPMENTAL DISABILITIES; DNA MUTATIONAL ANALYSIS; FEMALE; GENOTYPE; HUMANS; INFANT; INTELLECTUAL DISABILITY; LEARNING DISORDERS; MALE; NEOPLASMS; PEDIGREE; PHENOTYPE;

EID: 77955626857     PISSN: 19393792     EISSN: 19393806     Source Type: Journal    
DOI: 10.1002/aur.132     Document Type: Article

References (25)

1. Abrahams, B.S., & Geschwind, D.H. (2008). Advances in autism genetics: On the threshold of a new neurobiology. Nature Reviews Genetics, 9, 341-355.
2. Amir, R.E., Vanden Veyver, I.B.,Wan,M., Tran,C.Q., Francke, U., & Zoghbi, H.Y. (1999). Rett syndrome is caused bymutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nature Genetics, 23, 185-188. (Pubitemid 29455390)
3. Baker, P., Piven, J., & Sato, Y. (1998). Autism and tuberous sclerosis complex: Prevalence and clinical features. Journal of Autism and Developmental Disorders, 28, 279-285.
4. Butler, M.G., Dasouki, M.J., Zhou, X.P., Talebizadeh, Z., Brown, M., et al. (2005). Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. Journal of Medical Genetics, 42, 318-321.
5. Buxbaum, J.D., Cai, G., Chaste, P., Nygren, G., Goldsmith, J., et al. (2007). Mutation screening of the PTEN gene in patients with autism spectrum disorders and macrocephaly. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, 144B, 484-491. (Pubitemid 46983159)
6. Cook Jr, E.H., & Scherer, S.W. (2008). Copy-number variations associated with neuropsychiatric conditions. Nature, 455, 919-923.
7. Daly, M.B. (2009). NCCN Clinical Practice Guidelines in Oncology. Genetic/Familial High-Risk Assessment: Breast and Ovarian Retrieved December 18, 2009, v.I.2009, from www.nccn.org.
8. Goffin, A., Hoefsloot, L.H., Bosgoed, E., Swillen, A., & Fryns, J.P. (2001). PTEN mutation in a family with Cowden syndrome and autism. American Journal of Medical Genetics, 105, 521-524.
9. Han, S.Y., Kato, H., Kato, S., Suzuki, T., Shibata, H., et al. (2000). Functional evaluation of PTEN missense mutations using in vitro phosphoinositide phosphatase assay. Cancer Research, 60, 3147-3151.
10. Hatton, D.D., Sideris, J., Skinner, M., Mankowski, J., Bailey Jr., D.B., et al. (2006). Autistic behavior in children with fragile X syndrome: Prevalence, stability, and the impact of FMRP. American Journal of Medical Genetics Part A, 140A, 1804-1813. (Pubitemid 44330644)
11. Herman, G.E., Butter, E., Enrile, B., Pastore, M., Prior, T.W., & Sommer, A. (2007a). Increasing knowledge of PTEN germline mutations: Two additional patients with autism and macrocephaly. American Journal of Medical Genetics Part A, 143, 589-593.
12. Herman, G.E., Henninger, N., Ratliff-Schaub, K., Pastore, M., Fitzgerald, S., & McBride, K.L. (2007b). Genetic testing in autism: how much is enough? Genetics in Medicine, 9, 268-274.
13. Lainhart, J.E., Bigler, E.D., Bocian, M., Coon, H., Dinh, E., et al. (2006). Head circumference and height in autism: A study by the Collaborative Program of Excellence in Autism. American Journal of Medical Genetics Part A, 140, 2257-2274.
14. Maehama, T., & Dixon, J.E. (1999). PTEN: A tumour suppressor that functions as a phospholipid phosphatase. Trends in Cell Biology, 9, 125-128. (Pubitemid 29161437)
15. Maehama, T., Taylor, G.S., & Dixon, J.E. (2001). PTEN and myotubularin: Novel phosphoinositide phosphatases. Annual Review of Biochemistry, 70, 247-279.
16. Muhle, R., Trentacoste, S.V., & Rapin, I. (2004). The genetics of autism. Pediatrics, 113, e472-486.
17. Ng, P.C., & Henikoff, S. (2003). SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Research, 31, 3812-3814.
18. O'Roak, B.J., & State, M.W. (2008). Autism genetics: Strategies, challenges, and opportunities. Autism Research, 1, 4-17.
19. Orloff, M.S., & Eng, C. (2008). Genetic and phenotypic heterogeneity in the PTEN hamartoma tumour syndrome. Oncogene, 27, 5387-5397.
20. Parisi, M.A., Dinulos, M.B., Leppig, K.A., Sybert, V.P., Eng, C., & Hudgins, L. (2001). The spectrum and evolution of phenotypic findings in PTEN mutation positive cases of Bannayan-Riley-Ruvalcaba syndrome. Journal of Medical Genetics, 38, 52-58. (Pubitemid 32102325)
21. Schaefer, G.B., Mendelsohn, N.J., & Professional Practice and Guidelines, C. (2008). Clinical genetics evaluation in identifying the etiology of autism spectrum disorders. Genetics in Medicine, 10, 301-305.
22. Sunyaev, S., Ramensky, V., Koch, I., Lathe 3rd, W., Kondrashov, A.S., & Bork, P. (2001). Prediction of deleterious human alleles. Human Molecular Genetics, 10, 591-597.
23. Varga, E.A., Pastore, M., Prior, T., Herman, G.E., & McBride, K.L. (2009). The prevalence of PTEN mutations in a clinical pediatric cohort with autism spectrum disorders, developmental delay, and macrocephaly. Genetics in Medicine, 11, 111-117.
24. Zhou, X.P., Waite, K.A., Pilarski, R., Hampel, H., Fernandez, M.J., et al. (2003). Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway. American Journal of Human Genetics, 73, 404-411.
25. Zori, R.T., Marsh, D.J., Graham, G.E., Marliss, E.B., & Eng, C. (1998). Germline PTEN mutation in a family with Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome. American Journal of Medical Genetics, 80, 399-402. (Pubitemid 28541607)